Johnson & Johnson has made a significant acquisition, purchasing medical device maker Shockwave Medical for approximately $13.1 billion to strengthen the company's efforts in fighting heart disease.
Tags: Johnson & Johnson
Johnson & Johnson Commits $2 Billion to Boost American Jobs, Manufacturing Capacity
Johnson & Johnson is investing $2 billion to expand U.S. manufacturing and create jobs with a new facility in North Carolina.
Johnson & Johnson Plans Bankruptcy Filing to Finalize $6.48 Billion Talc Settlement
Johnson & Johnson is nearly announcing a $6.48 billion settlement to resolve talc-related cancer claims, with at least 75% of claimants supporting the deal. He plans to use a bankruptcy strategy to settle all current and future claims.
Johnson & Johnson Faces Fresh Lawsuit Seeking Damages, Cancer Monitoring for Talc Product Users
Johnson & Johnson is facing a new class action lawsuit seeking damages and medical monitoring for women potentially affected by cancer allegedly linked to the company's talc products.
Johnson & Johnson Ordered to Pay an Oregon Woman $260 Million After Getting Cancer Using the Powder
The 48-year-old Oregon woman claimed that she's been using Johnson & Johnson powder for 30 years and has been inhaling asbestos in return, but Johnson & Johnson maintained that their products do not contain such and do not cause cancer.
Latest News
Nvidia has partnered with Johnson & Johnson to develop new AI applications to help doctors perform surgery.
It's no longer unusual if you see working mothers in the office, streets, or restaurants. With the high cost of living, children's education, and bills to pay, couples should help each other to make both ends meet.
With an objective of taking additive manufacturing (3-D printing) to further advance level, America Makes has drawn up plans to support research and development (R&D) with financial funding of up to $8 million.
International Business Machines Corp, deepening its partnership with Apple Inc to make use of health information gathered by millions of Apple devices, is creating a unit dedicated to providing data analytics to the healthcare sector.
Belgian biotech group Galapagos said on Tuesday that its research partner Janssen Pharmaceutica, a unit of Johnson & Johnson, had pulled out of a program to develop a new drug to treat bowel disease.
U.S. medical device maker Medtronic (MDT.N) gained European Union regulatory approval on Friday for its $43 billion takeover of Covidien Plc (COV.N) after agreeing to sell its Irish rival's drug-coated balloon catheter business.
Nearly a decade after losing a bidding war for device maker Guidant to Boston Scientific Corp, Johnson & Johnson finally has a chance for payback at a multibillion-dollar trial set to begin on Thursday.
Johnson & Johnson (JNJ.N) agreed to pay $1.75 billion in cash to buy privately held Alios BioPharma Inc, which is developing a drug for a common respiratory viral infection in children for which there is no approved treatment.
Johnson & Johnson (JNJ.N) plans to seek a buyer for its medical device maker business, Cordis Corp, The Wall Street Journal reported citing people familiar with the matter.
